Cell signaling, induced by IL-11 and IL-6 and the downstream STAT3, may promote the breast cancer metastatic process by a wide range of molecular processes, and further studies that elaborate on the different tumor-promoting effects of IL-6 and IL-11 may lead to research into effective treatments for metastatic disease. This evidence concerns the gene STAT3 and neoplasm.